CN112618456B

CN112618456B - Oil control convergence suit and use method thereof

Info

Publication number: CN112618456B
Application number: CN202011641419.7A
Authority: CN
Inventors: 贺秋平; 彭燕辉; 许晓容; 彭婷婷; 廖友婷
Original assignee: Peng Shi Huizhou Industrial Development Co ltd
Current assignee: Peng Shi Huizhou Industrial Development Co ltd
Priority date: 2020-12-31
Filing date: 2020-12-31
Publication date: 2023-06-06
Anticipated expiration: 2040-12-31
Also published as: CN112618456A

Abstract

The invention belongs to the technical field of cosmetics, and discloses an oil control convergence suit and a use method thereof. The oil control convergence suit provided by the invention comprises oil control convergence emulsion, oil control convergence essence and oil control convergence water, and adopts a brand new oil control technology to fully exert the super-strong collocation effect of active ingredients, and particularly, the rosewood seed extract is matched with PCA zinc and zinc gluconate, so that the synthesis of sebum can be obviously reduced, excessive sebum overflow is removed, acne bacillus toxicity on skin is reduced, excessive keratinization is inhibited, and the medicinal layer porus has the effects of shrinking pores, tightening and moisturizing, and the convergence effect of witch hazel is reappeared, so that the oil secretion can be obviously controlled, the water-oil balance of skin is helped to be regulated, the skin function is improved, young vitality muscles are created, the skin is clean and healthy, the effects of fine and transparent are achieved, and the problem of external oil and internal dryness of oily skin is solved.

Description

Oil control convergence suit and use method thereof

Technical Field

The invention relates to the technical field of cosmetics, in particular to an oil control convergence suit and a use method thereof.

Background

The oily skin is characterized in that grease secretion is vigorous, forehead and nasal wings are oily, pores are large, blackheads are touched, cortex is thick and hard and is not smooth, appearance is dark yellow, skin is easy to absorb ultraviolet rays, along with the acceleration of modern life rhythm, life pressure of people is increased, environmental pollution is more and more serious, more and more people are afflicted with oily skin, people eat food for over-oil and pungent stimulus, and life work is irregular, and stay up night, so that excessive grease secretion is further aggravated, in general, hormone secretion imbalance, unbalanced diet and environmental factors are the reasons of excessive sebum secretion, and the problem of oily skin is solved for the global women with ages of 25-34, so that a plurality of oil control products exist on the market.

However, in order to achieve better oil control effect, the existing oil control package generally adds more oil control components, but ignores the moisturizing effect, that is, although the existing oil control package can solve the oil control problem, but cannot nourish the skin of oily skin people well, in particular, many oily skin people have the problem of dry skin in the external oil, and long-term use of the oil control product can further aggravate the problem of water shortage of the skin of the oily skin people dry in the external oil, so that the skin is fragile, for example, discomfort such as tight skin, stinging and the like occurs, and therefore, the research and development personnel in the field aim at the skin care product with mild oily skin people and good oil control effect.

Disclosure of Invention

In order to overcome the defects and shortcomings of the prior art, the primary aim of the invention is to provide the oil control convergence suit which can obviously control the secretion of grease, help to regulate the water-oil balance of skin, nourish the skin and improve the skin function.

The invention also aims to provide a using method of the oil control convergence suit.

In order to achieve the aim of the invention, the invention adopts the following technical scheme:

an oil control convergence suit comprises an oil control convergence emulsion, an oil control convergence essence and an oil control convergence water;

wherein, the oil control astringency emulsion comprises: water, glycerol, butylene glycol, glycerol polyether-26, 1, 2-hexanediol, sodium hyaluronate, beta-glucan, sodium polyglutamate, cyclopentadimethicone, dimethicone, hydrogenated polyisobutene, jojoba seed oil, antioxidants, emulsifiers, sodium polyacrylate, acrylic acid (esters) based/C10-30 alkanol acrylate cross-linked polymers, soothing agents, pH modifiers, chelating agents, trehalose, betaines, maltodextrin, witch hazel extract, rosewood seed extract and medicinal layer porus extract;

the oil control convergence essence comprises the following components: water, propylene glycol, butylene glycol, 1, 2-hexanediol, glycerin, PEG-40 hydrogenated castor oil, sodium hyaluronate, beta-glucan, polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer, silica, antioxidants, acrylic/C10-30 alkanol acrylate cross-linked polymer, soothing agents, pH adjusting agents, trehalose, nicotinamide, panthenol, maltodextrin, witch hazel extract, rosewood seed extract, medicinal layer porus extract, and zinc gluconate;

the oil control convergence water comprises: water, 1, 3-propanediol, 1, 2-hexanediol, glycerol, butanediol, PEG-40 hydrogenated castor oil, methyl glucitol polyether-20, antioxidants, soothing agents, menthol lactate, maltodextrin, papain, zinc PCA, medicinal Phellinus extract, and rosewood seed extract.

Preferably, the oil control astringent emulsion comprises the following components in parts by mass: 75 to 85 parts of water, 5 to 6 parts of glycerin, 5 to 6 parts of butanediol, 1 to 3 parts of glycerin polyether-26, 0.5 to 1 part of 1, 2-hexanediol, 0.01 to 0.03 part of sodium hyaluronate, 0.01 to 0.02 part of beta-glucan, 0.01 to 0.02 part of sodium polyglutamate, 1 to 3 parts of cyclopentamethylene siloxane, 1 to 2 parts of polydimethylsiloxane, 0.5 to 1.5 parts of hydrogenated polyisobutene, 0.4 to 0.6 part of jojoba seed oil, 0.5 to 0.8 part of antioxidant, 0.3 to 0.5 part of emulsifier, 0.2 to 0.4 part of sodium polyacrylate, 0.1 to 0.2 part of acrylic acid (ester) or C10-30 alkanol acrylate cross-linked polymer, 0.1 to 0.2 part of soothing agent, 0.05 to 0.1 part of pH regulator, 0.04 to 0.06 part of chelating agent, 0.3 to 0.5 part of seaweed, 0.001 to 0.02 part of pine extract, 0.01 to 0.02 part of pine cone extract, and 0.01 to 0.01 part of pine cone extract.

Preferably, the oil control convergence essence comprises the following components in parts by mass: 80 to 90 parts of water, 2 to 4 parts of propylene glycol, 1 to 3 parts of butanediol, 0.4 to 0.6 part of 1, 2-hexanediol, 0.01 to 0.05 part of glycerin, 0.05 to 0.2 part of PEG-40 hydrogenated castor oil, 0.01 to 0.03 part of sodium hyaluronate, 0.005 to 0.008 part of beta-glucan, 0.2 to 0.3 part of polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer, 0.2 to 0.3 part of silica, 0.4 to 0.6 part of antioxidant, 0.2 to 0.4 part of acrylic acid (esters) or C10-30 alkanol acrylate cross-linked polymer, 0.2 to 0.4 part of soothing agent, 0.1 to 0.2 part of pH regulator, 0.1 to 0.3 part of trehalose, 0.1 to 0.3 part of nicotinamide, 0.1 to 0.3 part of panthenol, 0.001 to 0.3 part of maltodextrin, 3 to 5 parts of witch hazel extract, 0.2 to 0.05 part of red-seed extract, and 0.05 to 2 parts of zinc extract.

Preferably, the oil control convergence water comprises the following components in parts by mass: 90 to 95 parts of water, 4 to 6 parts of 1, 3-propanediol, 0.4 to 0.6 part of 1, 2-hexanediol, 0.01 to 0.05 part of glycerin, 0.01 to 0.05 part of butanediol, 0.01 to 0.05 part of PEG-40 hydrogenated castor oil, 0.5 to 2 parts of methyl glucitol polyether-20, 0.4 to 0.6 part of antioxidant, 0.1 to 0.3 part of soothing agent, 0.01 to 0.05 part of menthol lactate, 0.001 to 0.005 part of maltodextrin, 0.01 to 0.05 part of papain, 0.1 to 0.3 part of PCA zinc, 0.05 to 0.2 part of medicinal layer porus extract and 0.01 to 0.05 part of rosewood seed extract.

Preferably, the antioxidants may be p-hydroxyacetophenone.

Preferably, the soothing agent may be the same or different and comprises at least one of flos Matricariae Chamomillae extract, flos Malva sylvestris extract, radix Paeoniae extract, flos Lonicerae extract, herba Taraxaci rhizome/root extract, herba Violae extract and Aloe vera leaf juice.

Preferably, the pH adjusting agents may be aminomethylpropanol.

Preferably, the emulsifier is PEG-20 methyl glucose sesquistearate.

Preferably, the chelating agent is disodium EDTA.

The invention also provides a use method of the oil control convergence suit, which sequentially comprises the following steps:

the first step, the oil control astringent emulsion is uniformly smeared on the skin;

secondly, uniformly coating the oil control convergence essence on the skin;

and thirdly, uniformly applying the oil-control astringent water on the skin.

The formula of the invention comprises the following components:

the zinc PCA adopted by the invention is a sebum regulator with excellent oil control effect, is particularly suitable for oily and acne skin, can prevent spots from forming, is used as a moisturizing factor in naturally-occurring skin, combines zinc to produce zinc PCA, has higher cation content than other forms of zinc, has higher cost performance, and better effect, can effectively remove excessive seborrhea, can effectively inhibit 5 alpha-reductase, inhibit sebum breeding and kill acne bacillus, has good inhibition effect on bacteria, mould and saccharomycetes, and thus prevents skin inflammation from irritating skin.

The rosewood seed extract adopted by the invention can obviously reduce lipid synthesis and sebaceous cell synthesis, and can block excessive keratinization, so that the rough pore symptom is improved, the rosewood seed extract can inhibit the lipase activity of acne bacillus although the growth of acne bacillus is not changed, oily skin can be obviously improved, sebaceous gland activity can be reduced, and the matt muscle effect is achieved.

The medicinal layer porus extract adopted by the invention is a medicinal mushroom extract growing in eastern Europe, has the effects of shrinking pores, tightening skin and remarkably preserving moisture, and has the immediate effect of remarkably shrinking pores.

The invention adopts the witch hazel extract, which is an effective skin astringing agent to help shrink pores and remove superfluous skin grease to prevent the growth of vaccinia, and the natural astringing property of the witch hazel extract can remove facial acne, bacteria and facial grease.

The invention also adopts zinc gluconate, the gluconic acid is an intelligent organic ion, and provides a carrier for mineral ions, so that the mineral ions have bioavailability, and the zinc gluconate can supplement cell energy and promote cell metabolism, thereby being beneficial to promoting the absorption and effective utilization of other active substances.

Compared with the prior art, the invention has the following advantages and technical effects:

(1) The oil control convergence suit provided by the invention adopts a brand new oil control technology, fully plays the super-strong collocation role of active ingredients, and particularly, the rosewood seed extract is matched with PCA zinc and zinc gluconate, so that sebum synthesis can be obviously reduced, excessive sebum overflow is removed, acne bacillus toxicity on skin is reduced, excessive keratinization is inhibited, and medicinal layer porus has the effects of shrinking pores, tightening and moisturizing, and then the convergence role of witch hazel is played, so that oil secretion can be obviously controlled, water-oil balance of skin is helped to be regulated, skin functions are improved, young vitality muscles are created, skin is clean and healthy, the effects of fine and smooth and transparent are achieved, and the problem of external oil and internal dryness of oily skin is solved.

(2) The oil control convergence suit provided by the invention comprises an oil control convergence emulsion, an oil control convergence essence and an oil control convergence water, and adopts unique 'emulsion first' collocation, namely, the oil control convergence suit provided by the invention is used sequentially by firstly smearing the oil control convergence emulsion, then smearing the oil control convergence essence and finally smearing the oil control convergence water.

Drawings

In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings that are needed in the embodiments will be briefly described below, it being understood that the following drawings only illustrate some embodiments of the present invention and therefore should not be considered as limiting the scope, and other related drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.

FIG. 1 is a plot of the results of satisfaction of all subjects of example 5 after use of the product;

fig. 2 is a self-evaluation result of all subjects of example 5 after using the product.

Detailed Description

The present invention will be described in further detail with reference to specific examples and drawings, but embodiments of the present invention are not limited thereto. All materials and reagents used in the present invention are commercially available conventional materials and reagents unless otherwise specified. The dosage of each component in the examples is g and mL in parts by mass and volume.

Examples 1 to 5

The oil control convergence packages of examples 1-5 wherein the oil control convergence emulsion comprises the components shown in table 1 in parts by mass.

TABLE 1 EXAMPLES 1 to 5 Convergence emulsion composition Table for oil control

/>

The formulations in table 1 were prepared as follows:

(1) Adding polydimethylsiloxane, hydrogenated polyisobutene, jojoba seed oil and PEG-20 methyl glucose sesquistearate into an oil phase pot according to a proportion, stirring, heating to 75-78 ℃, and uniformly mixing to obtain an oil phase;

(2) Adding water, trehalose and betaine into a water phase pot according to a proportion, stirring and heating to 80-82 ℃, adding glycerol, butanediol, glycerol polyether-26, acrylic acid (esters) or C10-30 alkanol acrylate cross-linked polymer, EDTA disodium, sodium hyaluronate, beta-glucan and sodium polyglutamate, and uniformly mixing to obtain a water phase;

(3) Homogenizing the oil phase and the water phase to obtain a blend solution A, uniformly stirring cyclopenta-dimethicone and sodium polyacrylate according to a proportion, adding the blend solution A, and homogenizing to obtain a blend solution B;

(4) Adding aminomethylpropanol into the blend B, stirring uniformly, cooling to 42-45 ℃, adding the hamamelis extract, 1, 2-hexanediol, p-hydroxyacetophenone, chamomile extract, mallow flower extract, paeonia lactiflora root extract, honeysuckle extract, dandelion rhizome/root extract, viola extract and aloe vera leaf juice mixture, rosewood seed extract, maltodextrin and medicinal layer porus extract, stirring uniformly, cooling to 30-36 ℃ and obtaining the oil-control convergence emulsion.

The oil control astringency essence comprises the components shown in a table 2 in parts by mass.

TABLE 2 EXAMPLES 1 to 5 Convergence essence composition tables for oil control

/>

The formulations in table 2 were prepared as follows:

(1) Adding water, acrylic acid (esters) C10-30 alkanol acrylate crosslinked polymer, sodium hyaluronate and beta-glucan into a pot according to a proportion, stirring, heating to 75 ℃, homogenizing for 5min, heating to 88-90 ℃, preserving heat for 10min, and then adding propylene glycol, butanediol, PEG-40 hydrogenated castor oil, trehalose, nicotinamide and zinc gluconate to obtain a mixed solution A;

(2) Cooling to 70-75 ℃, firstly dissolving 1, 2-hexanediol and p-hydroxyacetophenone according to a proportion completely, then adding the dissolved 1, 2-hexanediol and p-hydroxyacetophenone into the mixed solution A, stirring uniformly, cooling to 42-45 ℃, adding the rest components according to a proportion, stirring uniformly, cooling to 30-36 ℃ and obtaining the oil control convergence essence.

The oil control convergence water comprises the components shown in table 3 in parts by mass.

TABLE 3 EXAMPLES 1 to 5 Convergence Water component tables for oil control

The formulations in table 3 were prepared as follows:

(1) Adding water and 1, 3-propanediol into a pot according to a certain proportion, stirring, heating to above 70 ℃, homogenizing for 10min, heating to 88-90 ℃, preserving heat for 10min, and then adding methyl glucitol polyether-20 and PCA zinc to obtain a mixed solution B;

(2) Cooling to 70-75 ℃, firstly dissolving 1, 2-hexanediol and p-hydroxyacetophenone according to a proportion completely, then adding the dissolved 1, 2-hexanediol and p-hydroxyacetophenone into the mixed liquid B, stirring uniformly, cooling to 42-45 ℃, adding the rest components according to a proportion, stirring uniformly, cooling to 30-36 ℃ and obtaining the oil control convergence water.

The method for using the oil control convergence suit of the above embodiments 1 to 5 sequentially uses the following steps:

the first step, uniformly smearing the oil-control astringent emulsion on the skin;

secondly, uniformly smearing the oil control convergence essence on the skin;

and thirdly, uniformly applying the oil-control astringent water on the skin.

Blank control group

The blank group was not smeared with any product.

Comparative example 1

The difference between comparative example 1 and example 5 is that the oil control convergence kit sample of comparative example 1 does not contain witch hazel extract, rosewood seed extract, medicinal layer porus extract, zinc gluconate and zinc PCA, and other reagents are used in the same amounts and preparation methods as in example 5.

Comparative example 2

Comparative example 2 differs from example 5 in the method of use, and comparative example 2 uses the following steps in order:

the first step, evenly smearing oil-control astringent water on skin;

secondly, uniformly smearing the oil control convergence essence on the skin;

and thirdly, uniformly applying the oil-control astringent emulsion on the skin.

The amounts of reagents used and the preparation method were the same as in example 5.

Oil control and moisturizing efficacy test

The oil control and moisture retention efficacy test was performed using the oil control convergence kit prepared in example 5 and comparative examples 1 to 2 as an example.

The testing method comprises the following steps: left and right forehead random controls, left and right cheek random controls, double blind test.

Subject requirements: the test subjects were screened from the penny (wheatstone) industry development limited company factory for healthy subjects meeting the following inclusion and exclusion criteria:

inclusion criteria:

(1) Healthy people with ages of 18-30 years old are not limited by men and women;

(2) The skin is oily skin, has serious oil extraction, has larger pores and has no serious acne skin;

(3) The device can be well matched with testers, and can keep the regularity of life during the research period;

(4) The method can read and understand the knowledge, agree with all contents of the book, and sign the knowledge agreements voluntarily;

(5) No further clinical trials with any other study center were engaged during the trial;

(6) During the test, it was agreed that no cosmetics, drugs and health products having an influence on the results were used.

Exclusion criteria:

(1) Skin diseases or flaws exist at the test part, which may affect the judgment of the test result;

(2) Highly allergic constitution;

(3) Women who are pregnant, lactating, or are intended to be pregnant during the test;

(4) Patients with severe barycenter, liver and kidney function injury and severe hypoimmunity, or immunosuppressant in about one month;

(5) Those with mental illness, severe endocrine disease, and oral contraceptives;

(6) Clinical testers or other testers taking the drug within 30d, or those who use the drug with influence on the test result in nearly 1 week;

(7) Cosmetic products that may have an effect on the test results for oral and topical use within 2 weeks;

(8) The test person cannot be matched.

Data statistics: the data is counted by using SPSS, normal distribution inspection is carried out on the test data, and if the test data is normal distribution, a t-inspection method is adopted for statistical analysis; if the test data are in non-normal distribution, a rank sum test method is adopted for statistical analysis, two-tail test is adopted for the statistical methods, and a test level alpha=0.05.

Test items:

(1) Short term oil control-skin grease content test

The sample oil control convergence kit of example 5 was coated on the inner forehead in the order of (2.0±0.1) mg/cm2, the oil control convergence kit of comparative example 2 was coated on the inner forehead in the test area uniformly coated, and the sample oil control convergence kit of comparative example 5 was coated on the inner forehead in the test area uniformly coated in the order of (2.0±0.1) mg/cm2, the oil control convergence kit of comparative example 5 was coated on the test area uniformly coated as the first group, the oil control convergence kit of example 5 was coated on the inner forehead in the order of (2.0±0.1) mg/cm2, the oil control convergence kit was coated on the inner forehead in the test area uniformly coatedCoating the forehead inner side respectively according to the dosage of (2.0+ -0.1) mg/cm2, the oil control convergence emulsion, the oil control convergence essence and the oil control convergence water in sequence, uniformly coating the forehead inner side, testing with a blank control group as a second group, and testing with a skin grease test probe (CK in Germany

SM 815) the skin oil content of the left and right forehead inner side test areas was tested before use for 2h, 4h, and the specific results are shown in tables 4 and 5.

TABLE 4 Subjects at different time points in the first group of forehead medial skin lipid content (x+ -s)

TABLE 5 Subjects at the second set of different time points for forehead medial skin lipid content (x+ -s)

/>

Skin grease test probe (Germany CK)

SM 815) was used to detect skin oil content, higher test values indicated a high skin oil content. As can be seen from the data in Table 4, the difference between the measured value and the initial value of example 5 and comparative example 2 was compared at 2h, and the data were significantly different (P<0.05 The difference between the measured value and the initial value of example 5 and comparative example 2 was not significantly different at 4h (P>0.05 A) is provided; as can be seen from the data in Table 5, the difference between the measured value and the initial value of the two groups of example 5 and the blank group was compared at 2h and 4h, and the data were significantly different (P<0.05). In summary, the measured values at 2h and 4h were obtained in example 5The difference from the initial value and the blank data are reduced, which shows that the use of the embodiment 5 inhibits the increase of the content of normal grease secretion of the skin, and proves that the oil control convergence kit has obvious oil control effect; compared with the data of comparative example 2 in 2 hours, the data of example 5 shows that example 5 can inhibit the increase of the oil secretion content of skin more, and proves that the use method of the oil control convergence suit has better oil control effect, that is, experimental data show that the oil control convergence suit provided by the invention has better short-term oil control effect, the oil control effect is obvious, and especially, the oil control effect can be obviously improved according to the use sequence of emulsion, essence and water.

(2) Long term moisturizing skin moisture content test

After face cleaning, the oil control convergence kit of example 5 and comparative example 1 was sequentially and respectively applied to the left and right cheeks of a subject by taking 1-3 pumps in the order of oil control convergence emulsion, oil control convergence essence and oil control convergence water, rubbing the hands until warm, lightly wrapping the face to help absorption, twice a day in the morning and at the evening, and simultaneously detecting the moisture content of the horny layer of the left and right cheeks and cheeks by a skin moisture tester (CKEnneometer CM825 in Germany) for 2 weeks and 4 weeks before use, and the specific results are shown in Table 6.

TABLE 6 moisture content of the inner stratum corneum of the forearm (x.+ -. S) for subjects at various time points

The skin moisture meter corneometer cm825 was used to measure the skin stratum corneum moisture content, the higher the skin stratum corneum moisture content measurement, the higher the skin stratum corneum moisture content. As can be seen from the data in table 6, example 5 compares the facial moisture content of D14 to that before use, the data not having statistical significance (P > 0.05); the facial moisture content of example 5D28 was compared to before use, the data were statistically significant (P < 0.05); comparative example 1 the facial moisture content of D14, D28 was compared to before use, the data were statistically significant (P < 0.05). Experimental data show that the oil control convergence kit provided by the invention has the function of improving the skin moisture content for a long time and has a good moisturizing effect.

Summary of efficacy: as can be seen from the comparison of the effects of the example 5 and the comparative examples 1 and 2, the comparative examples 1 and 2 have certain effects of controlling oil and supplementing water under the condition of lacking certain specific components or different use sequences, but the effects are not obvious, so that the obvious water supplementing and oil controlling effects of the oil controlling convergence kit provided by the invention are generated by the synergistic effect of different components in the formula, and the oil controlling convergence kit has obvious oil controlling and moisturizing effects when used under the specific use method under the conditions of specific component selection, specific proportion and dosage range, that is, the oil controlling convergence kit provided by the invention has good comprehensive oil controlling and moisturizing effects of controlling oil for a long time, helping to regulate the water-oil balance of skin, improving the skin function, building younger muscles, enabling the skin to be clean and healthy, achieving the effects of fine and transparent and helping to solve the problem of oil drying outside the oily skin.

(3) Subject self-assessment

All subjects were subjected to a questionnaire, which is a subjective evaluation of the subjects using the product of example 5, with the following main evaluation items: the specific results of the tightening feeling, the absorption speed, the fineness of facial pores, the moisture degree, the smoothness of the skin, the greasy feeling of the face and the like are shown in fig. 1 and 2.

As can be seen from fig. 1, the volunteer satisfaction results after using the 28-day oil control convergence kit were: 93% of volunteers consider that the product is not tight after use, 100% of volunteers consider that the product is fast in absorption speed, 86% of volunteers consider that facial pores are finer after 4 weeks of use of the product, and 100% of volunteers consider that the product is more moist and moist, smoother and less greasy on the face after 4 weeks of use.

As can be seen from fig. 2, the volunteers self-evaluate the results after using the 28-day oil control convergence kit: volunteers consider that after the product is used for 4 weeks, skin moisture retention is increased by 73%, facial pores are fine and tired by 64%, skin smoothness is improved by 69%, and facial greasy feeling is reduced by 66%.

The results of efficacy evaluation of the samples prepared in examples 1-4 were similar to those of example 5.

Poor skin condition

During use of the samples, 0 subjects developed local erythema, papules, wheal, edema, or systemic adverse skin response.

The above examples are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above examples, and any other changes, modifications, substitutions, combinations, and simplifications that do not depart from the spirit and principle of the present invention should be made in the equivalent manner, and the embodiments are included in the scope of the present invention.

Claims

1. The application method of the oil control convergence suit is characterized by comprising the following steps of:

the oil control convergence suit comprises an oil control convergence emulsion, an oil control convergence essence and an oil control convergence water,

the using method comprises the following steps of:

the first step, evenly smearing the oil control convergence emulsion on skin, wherein the oil control convergence emulsion comprises the following components in parts by mass: 75 to 85 parts of water, 5 to 6 parts of glycerin, 5 to 6 parts of butanediol, 1 to 3 parts of glycerin polyether-26, 0.5 to 1 part of 1, 2-hexanediol, 0.01 to 0.03 part of sodium hyaluronate, 0.01 to 0.02 part of beta-glucan, 0.01 to 0.02 part of sodium polyglutamate, 1 to 3 parts of cyclopentadimethicone, 1 to 2 parts of polydimethylsiloxane, 0.5 to 1.5 parts of hydrogenated polyisobutene, 0.4 to 0.6 part of jojoba seed oil, 0.5 to 0.8 part of antioxidant, 0.3 to 0.5 part of emulsifier, 0.2 to 0.4 part of sodium polyacrylate, 0.1 to 0.2 part of acrylic acid (ester) or C10-30 alkanol acrylate cross-linked polymer, 0.1 to 0.2 part of soothing agent, 0.05 to 0.1 part of pH regulator, 0.04 to 0.06 part of chelating agent, 0.3 to 0.5 part of seaweed, 0.001 to 0.02 part of pine cone extract, 0.01 to 0.02 part of pine cone extract, and 0.01 to 0.01 part of pine cone extract;

the second step, evenly smearing the oil control convergence essence on the skin, wherein the oil control convergence essence comprises the following components in parts by mass: 80 to 90 parts of water, 2 to 4 parts of propylene glycol, 1 to 3 parts of butanediol, 0.4 to 0.6 part of 1, 2-hexanediol, 0.01 to 0.05 part of glycerin, 0.05 to 0.2 part of PEG-40 hydrogenated castor oil, 0.01 to 0.03 part of sodium hyaluronate, 0.005 to 0.008 part of beta-glucan, 0.2 to 0.3 part of polydimethylsiloxane/vinyl polydimethylsiloxane cross-linked polymer, 0.2 to 0.3 part of silica, 0.4 to 0.6 part of antioxidant, 0.2 to 0.4 part of acrylic acid (esters) or C10-30 alkanol acrylate cross-linked polymer, 0.2 to 0.4 part of soothing agent, 0.1 to 0.2 part of pH regulator, 0.1 to 0.3 part of trehalose, 0.1 to 0.3 part of nicotinamide, 0.1 to 0.3 part of panthenol, 0.001 to 0.3 part of maltodextrin, 3 to 5 parts of witch hazel extract, 0.2 to 0.05 part of red-seed extract, and 0.05 to 2 parts of zinc extract;

the third step, evenly smearing the oil control convergence water on the skin, wherein the oil control convergence water comprises the following components in parts by mass: 90 to 95 parts of water, 4 to 6 parts of 1, 3-propanediol, 0.4 to 0.6 part of 1, 2-hexanediol, 0.01 to 0.05 part of glycerin, 0.01 to 0.05 part of butanediol, 0.01 to 0.05 part of PEG-40 hydrogenated castor oil, 0.5 to 2 parts of methyl glucitol polyether-20, 0.4 to 0.6 part of antioxidant, 0.1 to 0.3 part of soothing agent, 0.01 to 0.05 part of menthol lactate, 0.001 to 0.005 part of maltodextrin, 0.01 to 0.05 part of papain, 0.1 to 0.3 part of PCA zinc, 0.05 to 0.2 part of medicinal layer porus extract and 0.01 to 0.05 part of rosewood seed extract;

the antioxidants are p-hydroxyacetophenone;

the soothing agent of the oil control astringent emulsion, the soothing agent of the oil control astringent essence and the soothing agent of the oil control astringent water are the same or different and respectively comprise at least one of chamomile flower extract, malva sylvestris extract, paeonia root extract, honeysuckle flower extract, dandelion rhizome/root extract, viola yedoensis extract and aloe vera leaf juice;

the emulsifier is PEG-20 methyl glucose sesquistearate.

2. The method of use according to claim 1, wherein: the pH regulator is aminomethylpropanol.

3. The method of use according to claim 1, wherein: the chelating agent is disodium EDTA.